TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,493,000 | -31.6% | 151,750 | -22.9% | 0.24% | -30.3% |
| Q4 2019 | $2,184,000 | +71.6% | 196,750 | -13.2% | 0.35% | +86.2% |
| Q3 2019 | $1,273,000 | -28.8% | 226,750 | +9.7% | 0.19% | -28.8% |
| Q2 2019 | $1,788,000 | +37.5% | 206,750 | +27.8% | 0.26% | +50.0% |
| Q1 2019 | $1,300,000 | +956.9% | 161,750 | +439.2% | 0.18% | +826.3% |
| Q4 2018 | $123,000 | -26.8% | 30,000 | 0.0% | 0.02% | +18.8% |
| Q3 2018 | $168,000 | -48.9% | 30,000 | +20.0% | 0.02% | -66.0% |
| Q2 2018 | $329,000 | -22.8% | 25,000 | -16.7% | 0.05% | -21.7% |
| Q1 2018 | $426,000 | -28.2% | 30,000 | -40.0% | 0.06% | -29.4% |
| Q3 2017 | $593,000 | +17.9% | 50,000 | 0.0% | 0.08% | +10.4% |
| Q2 2017 | $503,000 | -13.7% | 50,000 | 0.0% | 0.08% | -13.5% |
| Q1 2017 | $583,000 | +150.2% | 50,000 | 0.0% | 0.09% | +134.2% |
| Q4 2016 | $233,000 | -14.0% | 50,000 | +42.9% | 0.04% | -7.3% |
| Q3 2016 | $271,000 | – | 35,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |